Research ArticleArticle
Open Access
Incidence and Management of Infusion Reactions to Infliximab in a Prospective Real-world Community Registry
Denis Choquette, Rafat Faraawi, Andrew Chow, Jude Rodrigues, William J. Bensen and Francois Nantel
The Journal of Rheumatology July 2015, 42 (7) 1105-1111; DOI: https://doi.org/10.3899/jrheum.140538
Denis Choquette
From the Institut de Rhumatologie de Montréal, Montréal, Quebec; McMaster University, Hamilton; Credit Valley Hospital, Mississauga; Clinical Research and Arthritis Centre, Windsor; Janssen Inc., Toronto, Ontario,
Canada.
Rafat Faraawi
Andrew Chow
Jude Rodrigues
William J. Bensen
Francois Nantel
REFERENCES
- 1.↵
- 2.↵
- 3.↵
- 4.↵
- 5.↵
- 6.↵
- 7.↵
- Wasserman MJ,
- Weber DA,
- Guthrie JA,
- Bykerk VP,
- Lee P,
- Keystone EC
- 8.↵
- Kelsall J,
- Rogers P,
- Galindo G,
- De Vera MA
- 9.↵
- Keshavarzian A,
- Mayer L,
- Salzberg B,
- Garone M,
- Finkelstein W,
- Cappa J,
- et al.
- 10.↵
- 11.↵
- 12.↵
- 13.↵
- Sany J,
- Kaiser MJ,
- Jorgensen C,
- Trape G
In this issue
The Journal of Rheumatology
Vol. 42, Issue 7
1 Jul 2015
Incidence and Management of Infusion Reactions to Infliximab in a Prospective Real-world Community Registry
Denis Choquette, Rafat Faraawi, Andrew Chow, Jude Rodrigues, William J. Bensen, Francois Nantel
The Journal of Rheumatology Jul 2015, 42 (7) 1105-1111; DOI: 10.3899/jrheum.140538